Literature DB >> 23281917

Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.

Sumita Paul1, Abhinesh Kumar, Pramod Yedurkar, Krutika Sawant.   

Abstract

The objective of this investigation was to design and develop water-in-oil-in-water type multiple emulsions (w/o/w emulsions) entrapping acyclovir for improving its oral bioavailability. Multiple emulsions (MEs) were prepared and optimized using Span-80 and Span-83 as lipophilic surfactant and Brij-35 as hydrophilic surfactant. The physio-chemical properties of the w/o/w emulsions - particle size, viscosity, phase separation (centrifugation test) and entrapment efficiency were measured and evaluated along with macroscopic and microscopic observations to confirm multiple nature, homogeneity and globule size. Stability study, in vitro and ex vivo release studies were performed followed by in vivo studies in rats. Stable w/o/w emulsions with a particle size of 33.098 ± 2.985 µm and 85.25 ± 4.865% entrapment efficiency were obtained. Stability studies showed that the concentration of lipophilic surfactant was very important for stability of MEs. Drug release from the prepared formulations showed initial rapid release followed by a much slower release. In vivo studies in rats indicated prolonged release and better oral bioavailability as compared to drug solution. The overall results of this study show the potential of the w/o/w emulsions as promising drug delivery systems for acyclovir.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281917     DOI: 10.3109/03639045.2012.738682

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.

Authors:  Soyoung Shin; Tae Hwan Kim; Seok Won Jeong; Seung Eun Chung; Da Young Lee; Do-Hyung Kim; Beom Soo Shin
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

2.  A Brain-Targeted Approach to Ameliorate Memory Disorders in a Sporadic Alzheimer's Disease Mouse Model via Intranasal Luteolin-Loaded Nanobilosomes.

Authors:  Manal A Elsheikh; Yasmin A El-Feky; Majid Mohammad Al-Sawahli; Merhan E Ali; Ahmed M Fayez; Haidy Abbas
Journal:  Pharmaceutics       Date:  2022-03-05       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.